255 related articles for article (PubMed ID: 16636128)
1. A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.
Morel CF; Thomas MA; Cao H; O'Neil CH; Pickering JG; Foulkes WD; Hegele RA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2689-95. PubMed ID: 16636128
[TBL] [Abstract][Full Text] [Related]
2. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
3. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
5. Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
Patni N; Xing C; Agarwal AK; Garg A
Am J Med Genet A; 2017 Sep; 173(9):2517-2521. PubMed ID: 28686329
[TBL] [Abstract][Full Text] [Related]
6. The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy.
Muschke P; Kölsch U; Jakubiczka S; Wieland I; Brune T; Wieacker P
Am J Med Genet A; 2007 Dec; 143A(23):2810-4. PubMed ID: 18041775
[TBL] [Abstract][Full Text] [Related]
7. Laminopathies and atherosclerosis.
Al-Shali KZ; Hegele RA
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1591-5. PubMed ID: 15205220
[TBL] [Abstract][Full Text] [Related]
8. High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.
Deng M; Chen W; Qi Y
Comb Chem High Throughput Screen; 2024; 27(2):346-351. PubMed ID: 37231758
[TBL] [Abstract][Full Text] [Related]
9. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation.
Jacob KN; Baptista F; dos Santos HG; Oshima J; Agarwal AK; Garg A
J Clin Endocrinol Metab; 2005 Dec; 90(12):6699-706. PubMed ID: 16174718
[TBL] [Abstract][Full Text] [Related]
11. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
[TBL] [Abstract][Full Text] [Related]
12. A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
Le Dour C; Schneebeli S; Bakiri F; Darcel F; Jacquemont ML; Maubert MA; Auclair M; Jeziorowska D; Reznik Y; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2011 May; 96(5):E856-62. PubMed ID: 21346069
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
14. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
[TBL] [Abstract][Full Text] [Related]
15. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
[TBL] [Abstract][Full Text] [Related]
16. Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription.
Capanni C; Cenni V; Mattioli E; Sabatelli P; Ognibene A; Columbaro M; Parnaik VK; Wehnert M; Maraldi NM; Squarzoni S; Lattanzi G
Exp Cell Res; 2003 Nov; 291(1):122-34. PubMed ID: 14597414
[TBL] [Abstract][Full Text] [Related]
17. Familial partial lipodystrophy presenting as metabolic syndrome.
Chan D; McIntyre AD; Hegele RA; Don-Wauchope AC
J Clin Lipidol; 2016; 10(6):1488-1491. PubMed ID: 27919367
[TBL] [Abstract][Full Text] [Related]
18. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy.
Motsch I; Kaluarachchi M; Emerson LJ; Brown CA; Brown SC; Dabauvalle MC; Ellis JA
Eur J Cell Biol; 2005 Sep; 84(9):765-81. PubMed ID: 16218190
[TBL] [Abstract][Full Text] [Related]
19. Type A insulin resistance syndrome revealing a novel lamin A mutation.
Young J; Morbois-Trabut L; Couzinet B; Lascols O; Dion E; Béréziat V; Fève B; Richard I; Capeau J; Chanson P; Vigouroux C
Diabetes; 2005 Jun; 54(6):1873-8. PubMed ID: 15919811
[TBL] [Abstract][Full Text] [Related]
20. Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype.
Lombardi F; Gullotta F; Columbaro M; Filareto A; D'Adamo M; Vielle A; Guglielmi V; Nardone AM; Azzolini V; Grosso E; Lattanzi G; D'Apice MR; Masala S; Maraldi NM; Sbraccia P; Novelli G
J Clin Endocrinol Metab; 2007 Nov; 92(11):4467-71. PubMed ID: 17848409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
